1-2 of 2
Elizabeth Garrett-Mayer
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Effector CD8+ T-cell Engraftment and Antitumor Immunity in Lymphodepleted Hosts Is IL7Rα Dependent

Free
C. Bryce Johnson, Brian P. Riesenberg, Bennett R. May, Stuart C. Gilreath, Guangfu Li, Kevin F. Staveley-O'Carroll, Elizabeth Garrett-Mayer, Shikhar Mehrotra, David J. Cole, Mark P. Rubinstein
Journal: Cancer Immunology Research
Cancer Immunol Res (2015) 3 (12): 1364–1374.
https://doi.org/10.1158/2326-6066.CIR-15-0087-T
Published: 06 December 2015
View articletitled, Effector CD8+ T-cell Engraftment and Antitumor Immunity in Lymphodepleted Hosts Is IL7Rα Dependent
Open the PDF for Effector CD8+ T-cell Engraftment and Antitumor Immunity in Lymphodepleted Hosts Is IL7Rα Dependent in another window
Includes: Supplementary data
Journal Articles

A Feasibility Study of Cyclophosphamide, Trastuzumab, and an Allogeneic GM-CSF–Secreting Breast Tumor Vaccine for HER2+ Metastatic Breast Cancer

Free
Gang Chen, Richa Gupta, Silvia Petrik, Marina Laiko, James M. Leatherman, Justin M. Asquith, Maithili M. Daphtary, Elizabeth Garrett-Mayer, Nancy E. Davidson, Kellie Hirt, Maureen Berg, Jennifer N. Uram, Tianna Dauses, John Fetting, Elizabeth M. Duus, Saadet Atay-Rosenthal, Xiaobu Ye, Antonio C. Wolff, Vered Stearns, Elizabeth M. Jaffee, Leisha A. Emens
Journal: Cancer Immunology Research
Cancer Immunol Res (2014) 2 (10): 949–961.
https://doi.org/10.1158/2326-6066.CIR-14-0058
Published: 02 October 2014
View articletitled, A Feasibility Study of Cyclophosphamide, Trastuzumab, and an Allogeneic GM-CSF–Secreting Breast Tumor Vaccine for HER2+ Metastatic Breast Cancer
Open the PDF for A Feasibility Study of Cyclophosphamide, Trastuzumab, and an Allogeneic GM-CSF–Secreting Breast Tumor Vaccine for HER2+ Metastatic Breast Cancer in another window